Cargando…

Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation

Increased proinflammatory interleukin-6 (IL-6) levels are associated with acquired long QT-syndrome (LQTS) in patients with systemic inflammation, leading to higher risks for life-threatening polymorphic ventricular tachycardia such as Torsades de Pointes. However, the functional and molecular mecha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aromolaran, Ademuyiwa S., Srivastava, Ujala, Alí, Alessandra, Chahine, Mohamed, Lazaro, Deana, El-Sherif, Nabil, Capecchi, Pier Leopoldo, Laghi-Pasini, Franco, Lazzerini, Pietro Enea, Boutjdir, Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283635/ https://www.ncbi.nlm.nih.gov/pubmed/30521586 http://dx.doi.org/10.1371/journal.pone.0208321

Ejemplares similares

Anti-Ro/SSA Antibodies and the Autoimmune Long-QT Syndrome
por: Lazzerini, Pietro Enea, et al.
Publicado: (2021)

Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies
por: Lazzerini, Pietro Enea, et al.
Publicado: (2018)

Long QT Syndrome: An Emerging Role for Inflammation and Immunity
por: Lazzerini, Pietro Enea, et al.
Publicado: (2015)

Commentary: Systemic effects of IL-17 in inflammatory arthritis
por: Lazzerini, Pietro Enea, et al.
Publicado: (2019)

Inflammatory cytokines and cardiac arrhythmias: the lesson from COVID-19
por: Lazzerini, Pietro Enea, et al.
Publicado: (2022)

Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls
por: Lazzerini, Pietro Enea, et al.
Publicado: (2016)

Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities
por: Qu, Yongxia Sarah, et al.
Publicado: (2019)

Risk of QTc Interval Prolongation Associated With Circulating Anti‐Ro/SSA Antibodies Among US Veterans: An Observational Cohort Study
por: Lazzerini, Pietro Enea, et al.
Publicado: (2021)

Cardiac Ion Channel Regulation in Obesity and the Metabolic Syndrome: Relevance to Long QT Syndrome and Atrial Fibrillation
por: Aromolaran, Ademuyiwa S., et al.
Publicado: (2017)

Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis
por: Lazzerini, Pietro Enea, et al.
Publicado: (2016)

mTOR Modulation of I(Kr) through hERG1b-Dependent Mechanisms in Lipotoxic Heart
por: Aromolaran, Kelly A., et al.
Publicado: (2022)

Fir(e)ing the Rhythm: Inflammatory Cytokines and Cardiac Arrhythmias
por: Lazzerini, Pietro Enea, et al.
Publicado: (2023)

Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin‐6–Mediated Changes in Connexin Expression
por: Lazzerini, Pietro Enea, et al.
Publicado: (2019)

Transient Hypogonadism Is Associated With Heart Rate–Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men
por: Lazzerini, Pietro Enea, et al.
Publicado: (2021)

Reply: The Role of Inflammation and Gender Differences in the Pathogenesis of Cardiac Arrhythmias
por: Lazzerini, Pietro Enea, et al.
Publicado: (2023)

Isolated atrioventricular block of unknown origin in the adult and autoimmunity: diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA–associated cases
por: Lazzerini, Pietro Enea, et al.
Publicado: (2015)

Interleukin-6 Elevation Is a Key Pathogenic Factor Underlying COVID-19-Associated Heart Rate-Corrected QT Interval Prolongation
por: Lazzerini, Pietro Enea, et al.
Publicado: (2022)

hERG channel function: beyond long QT
por: Babcock, Joseph J, et al.
Publicado: (2013)

Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes
por: Lazzerini, Pietro Enea, et al.
Publicado: (2020)

Cardiolipotoxicity, Inflammation, and Arrhythmias: Role for Interleukin-6 Molecular Mechanisms
por: Alí, Alessandra, et al.
Publicado: (2019)

Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
por: Lazzerini, Pietro Enea, et al.
Publicado: (2016)

Unravelling Atrioventricular Block Risk in Inflammatory Diseases: Systemic Inflammation Acutely Delays Atrioventricular Conduction via a Cytokine‐Mediated Inhibition of Connexin43 Expression
por: Lazzerini, Pietro Enea, et al.
Publicado: (2021)

hERG1a N-terminal eag domain–containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: A possible mechanism for long QT syndrome
por: Trudeau, Matthew C., et al.
Publicado: (2011)

Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases
por: Zhu, Xiaojia, et al.
Publicado: (2022)

Drug-Associated QTc Prolongation in Geriatric Hospitalized Patients: A Cross-Sectional Study in Internal Medicine
por: Rossi, Marco, et al.
Publicado: (2021)

Acquired Long QT Syndrome and Electrophysiology of Torsade de Pointes
por: El-Sherif, Nabil, et al.
Publicado: (2019)

Association of the hERG mutation with long-QT syndrome type 2, syncope and epilepsy
por: LI, GUOLIANG, et al.
Publicado: (2016)

Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block
por: Tran, Phu N., et al.
Publicado: (2020)

Functional and pharmacological characterization of an S5 domain hERG mutation associated with short QT syndrome
por: Butler, Andrew, et al.
Publicado: (2019)

hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation
por: Chang, Yun, et al.
Publicado: (2021)

Pharmacological activation of the hERG K(+) channel for the management of the long QT syndrome: A review
por: El Harchi, Aziza, et al.
Publicado: (2022)

The electric heart of hERG
por: Islas, León D.
Publicado: (2013)

An Update on the Structure of hERG
por: Butler, Andrew, et al.
Publicado: (2020)

Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?”
por: Capecchi, Pier Leopoldo, et al.
Publicado: (2021)

Pathophysiology of Ca(v)1.3 L-type calcium channels in the heart
por: Zaveri, Sahil, et al.
Publicado: (2023)

Action potential clamp characterization of the S631A hERG mutation associated with short QT syndrome
por: Butler, Andrew, et al.
Publicado: (2018)

The N-linker region of hERG1a upregulates hERG1b potassium channels
por: Johnson, Ashley A., et al.
Publicado: (2022)

Computational Analysis of the Mode of Action of Disopyramide and Quinidine on hERG-Linked Short QT Syndrome in Human Ventricles
por: Whittaker, Dominic G., et al.
Publicado: (2017)

In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome
por: Whittaker, Dominic G., et al.
Publicado: (2019)

Electrophysiological characterization of the modified hERG(T) potassium channel used to obtain the first cryo‐EM hERG structure
por: Zhang, Yihong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i4iian6ibhgsrluo1g0trs31vi